New hope for tough blood cancers: early trial of ONO-7018 begins
NCT ID NCT05515406
First seen Jun 05, 2026 · Last updated Jun 05, 2026
Summary
This early-stage study tested a new drug called ONO-7018 in 9 adults with non-Hodgkin lymphoma or chronic lymphocytic leukemia that had returned or stopped responding to other treatments. The main goal was to find a safe dose and check for side effects. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AMR Kansas City
Kansas City, Missouri, 64114, United States
-
Baylor Scott & White Research Institute
Dallas, Texas, 75246, United States
-
Jonsson Comprehensive Cancer Center
Santa Monica, California, 90404, United States
-
Leo Jenkins Cancer Center/ECU School of Medicine
Greenville, North Carolina, 27858, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Northwest Medical Specialities
Tacoma, Washington, 98405, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Summit Medical Group
Florham Park, New Jersey, 07932, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.